Drive testing has always provided critical data for optimising cellular networks, but recent technology changes have caused some players to declare the near-term demise of drive testing and the associated software and hardware market. However, important use cases will still require this labour-intensive activity, and will continue to through 5G and beyond.
Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for serious and life-threatening rare diseases. The companys pipeline products include
Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly known as Bellerophon Therapeutics LLC, focuses on the development of products with the combination of drugs and devices for the treatment of cardiopulmonary diseases.
BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance, Inc. is a biotechnology company that develops products and therapies using cell and tissue protocols. The company performs stem cell programs which
Household sizes are rapidly changing worldwide, creating new consumer trends and changing the behaviour patterns of household dwellers. Households are contracting in terms of inhabitants but growing in terms of
USD 1325View Report
There are multiple drivers for HNW offshore investment. At a global level, almost a quarter of HNW individuals invest their assets offshore to gain access to a better or wider
USD 5250View Report
PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)
|Published Date||:||Sep 2016|
|No. of Pages||:||11|
|Publisher||:||Analysys Mason Limited|
|Report Delivery By||:|
|Report Delivery Time||:||12 to 24 hours after placing the order.|
If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE